Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study

NCT03524534 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT03524534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03524534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study
Lead sponsor
Kaiser Permanente
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2017
Completion date
December 31, 2018
Enrollment
2,091 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure